期刊文献+

Rabdosia serra alleviates dextran sulfate sodium salt-induced colitis in mice through anti-inflammation,regulating Th17/Treg balance,maintaining intestinal barrier integrity,and modulating gut microbiota 被引量:7

下载PDF
导出
摘要 Rabdosia serra(R.serra),an important component of Chinese herbal tea,has traditionally been used to treat hepatitis,jaundice,cholecystitis,and colitis.However,the chemical composition of R.serra and its effect against colitis remain unclear.In this study,the chemical composition of the water extract of R.serra was analyzed using ultra performance liquid chromatography coupled with a hybrid linear ion trap quadrupole-orbitrap mass spectrometer(UPLC-LTQ-Orbitrap-MS).A total of 46 compounds,comprising ent-kaurane diterpenoids,flavonoids,phenolic acids,and steroids,were identified in the water extract of R.serra,and the extract could significantly alleviate dextran sulfate sodium salt-induced colitis by improving colon length,upregulating anti-inflammatory factors,downregulating proinflammatory factors,and restoring the balance of T helper 17/T regulatory cells.R.serra also preserved intestinal barrier function by increasing the level of tight junction proteins(zonula occludens 1 and occludin)in mouse colonic tissue.In addition,R.serra modulated the gut microbiota composition by increasing bacterial richness and diversity,increasing the abundance of beneficial bacteria(Muribaculaceae,Bacteroides,Lactobacillus,and Prevotellaceae_UCG-001),and decreasing the abundance of pathogenic bacteria(Turicibacter,Eubacterium_fissicatena_group,and Eubacterium_xylanophilum_group).Gut microbiota depletion by antibiotics further confirmed that R.serra alleviated colitis in a microbiota-dependent manner.Overall,our findings provide chemical and biological evidence for the potential application of R.serra in the management of colitis.
出处 《Journal of Pharmaceutical Analysis》 SCIE CAS CSCD 2022年第6期824-838,共15页 药物分析学报(英文版)
基金 supported by the Science and Technology Development Fund of Macao,China(File No.:0151/2020/A3) Key Area Research and Development Program of Guangdong Province,China(Grant No.:2020B1111110003) the Research Fund of the University of Macao,Macao,China(File No.:MYRG2020-00141-ICMS) the Research Fund of Southwest Medical University,China(Grant No.:2021ZKZD017).
  • 相关文献

参考文献1

二级参考文献5

  • 1[1]Zhong Yao Da Ci Dian,Jiangshu New Medical College,Shanghai People Press,Shanghai,1977,p.2511.
  • 2[2]X.Li,W.L.Xiao,S.X.Huang,Z.Y.Weng,Y.H.Shen,Q.B.Han,H.D.Sun,Helv.Chim.Acta 89 (2006) 1181.
  • 3[3]H.D.Sun,S.X.Qiu,E.B.Lobkovsky,L.Z.Lin,N.R.Farnsworth,J.Clardy,H.S.Fong,Tetrahedron 57 (2001) 65.
  • 4[4]E.Fujita,T.Fujita,M.Taoka,Chem.Pharm.Bull.21 (1973) 1357.
  • 5[5]S.N.Chen,S.Y.Chen,Z.W.Lin,Chin.Chem.Lett.9 (1998) 1021.

共引文献2

同被引文献54

引证文献7

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部